VRSK
30
-39
AES
49
-2
ITW
39
2
IVZ
68
2
TXN
48
-22
THC
45
-17
USB
64
-12
HIG
62
2
AMG
71
-3
PEP
38
-18
ZION
68
-12
IRM
31
-10
BK
66
-2
NWL
61
3
TJX
65
-4
DE
46
-3
SPG
46
-18
ADI
70
-6
D
48
3
OKE
61
2
VRSK
30
-39
AES
49
-2
ITW
39
2
IVZ
68
2
TXN
48
-22
THC
45
-17
USB
64
-12
HIG
62
2
AMG
71
-3
PEP
38
-18
ZION
68
-12
IRM
31
-10
BK
66
-2
NWL
61
3
TJX
65
-4
DE
46
-3
SPG
46
-18
ADI
70
-6
D
48
3
OKE
61
2
Financhill
Back

Vanguard Short-Term Tax-Exempt Bond ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
43

VTES
Vanguard Short-Term Tax-Exempt Bond ETF

Last Price:
$101.58
Seasonality Move:
1.31%
Sell
50

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$111.76
Seasonality Move:
-13.08%
Sell
43
Vanguard Short-Term Tax-Exempt Bond ETF (VTES) is a Sell

Is Vanguard Short-Term Tax-Exempt Bond ETF a Buy, Sell or Hold?

  • The current Vanguard Short-Term Tax-Exempt Bond ETF [VTES] share price is $101.56. The Score for VTES is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • VTES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.86. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VTES Stock Price Chart

What is Vanguard Short-Term Tax-Exempt Bond ETF's stock price today?

  • The Vanguard Short-Term Tax-Exempt Bond ETF share price today is $101.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTES is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

VTES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.1 Buy
Relative Strength Index (14 RSI): 53.44 Buy
Chaikin Money Flow: 259166 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.43 - 101.57) Buy
Bollinger Bands (100): (101.41 - 101.89) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.92 Buy
Relative Strength Index (14 RSI): 57.01 Buy
Chaikin Money Flow: -264527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.99 - 110.55) Buy
Bollinger Bands (100): (94.91 - 108.39) Buy

VTES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.51 Buy
20-day SMA: 101.5 Buy
50-day SMA: 101.55 Buy
200-day SMA: 101.03 Buy
8-day EMA: 22.57 Buy
20-day EMA: 9.67 Buy
50-day EMA: 3.98 Buy
200-day EMA: 1.01 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.83 Buy
20-day SMA: 106.87 Buy
50-day SMA: 105.94 Buy
200-day SMA: 82.62 Buy
8-day EMA: 24.86 Buy
20-day EMA: 10.65 Buy
50-day EMA: 4.39 Buy
200-day EMA: 1.11 Buy

Vanguard Short-Term Tax-Exempt Bond ETF Earnings Growth & VTES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

Vanguard Short-Term Tax-Exempt Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):